Drug Channels

APRIL 2, 2025

This week, Im rerunning some popular posts while I prepare for Fridays live video webinar: PBM Industry Update: Trends, Challenges, and Whats Ahead. Minnesota just released the industrys first ever mandated financial report on the 340B Drug Pricing Program. Click here to see the original post from December 2024.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

DECEMBER 15, 2023

This week, I’m rerunning some popular posts while I prepare for today’s Drug Channels Outlook 2024 live video webinar. Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. The difference between list prices and discounted 340B purchases also grew, to $52.3 billion (+$2.6

Drug Pricing 98

Drug Pricing Hospitals 98

Drug Channels

APRIL 1, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers.

Drug Pricing 98

Drug Pricing Hospitals 98

Drug Channels

JUNE 12, 2024

Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program. Fein, Ph.D., All rights reserved.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

JULY 12, 2022

Despite what you may have heard, pharmacy participation in the 340B Drug Pricing Program continues to thrive. Drug Channels Institute’s latest analysis reveals that an astonishing 32,000 pharmacy locations —more than half of the entire U.S. d/b/a Drug Channels Institute. Read on for details and my commentary below.

Drug Pricing 98

Drug Pricing Hospitals 98

Drug Channels

OCTOBER 2, 2024

Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program. Fein, Ph.D., All rights reserved.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Specialty Pharmacies 75

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 75

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Drug Pricing 75

Drug Pricing Biosimilars Hospitals 75

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Specialty Pharmacies 75

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 75

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Drug Pricing 74

Drug Pricing Biosimilars Hospitals 74

Drug Channels

JUNE 8, 2021

That means it’s time to update Drug Channels Institute’s (DCI) annual analysis of pharmacist salaries and employment. We have found that the share of pharmacists who work at hospitals reached a new high. The 340B Drug pricing Program is a crucial topic for pharmacists. to 1:30 p.m. CLICK HERE TO LEARN MORE AND SIGN UP.

Hospitals 40

Hospitals Physician Offices Drug Pricing 40

Drug Channels

NOVEMBER 22, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Specialty Pharmacies 75

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 75

Drug Channels

JUNE 15, 2021

Drug Channels Institute’s latest review of contract pharmacies in the 340B Drug Pricing Program reveals that an astonishing 30,000 pharmacy locations—half of the entire U.S. pharmacy industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. One important update to the figures below: We (and many others) had significantly underestimated Walgreens' revenues and market share.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Hospitals 52

Drug Channels

MARCH 26, 2021

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs. Click here to read the Drug Channels Institute letter. d/b/a Drug Channels Institute. Click here to see the original post and comments from November 2020.

Drug Pricing 52

Drug Pricing Hospitals 52

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). Finally, we encourage CMS to consider a longer time horizon for the submission of data.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Drug Channels

DECEMBER 16, 2020

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Drug Channels Outlook 2021. I'll share my thoughts on the latest developments during this Friday's webinar. Last Friday, The Wall Street Journal published my opinion piece: The Federal Program That Keeps Insulin Prices High.

Drug Pricing 40

Drug Pricing Hospitals 40

Drug Channels

NOVEMBER 23, 2021

Recent posts have covered: outcomes-based contracts, copay accumulators, hospitals’ drug profits, biosimilar interchangeability, managed Medicaid, DSCSA, CVS Health’s networks, unintended consequences of congressional drug pricing legislation, Walmart and TRICARE, McKesson’s European retreat, and more. to 1:30 p.m.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 40

Drug Channels

SEPTEMBER 22, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. Despite what you may have heard, the 340B Drug Pricing Program continues to thrive. Click here to see the original post and comments from June 2021.

Drug Pricing 45

Drug Pricing Hospitals 45

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. The video is excerpted from my recent Drug Channels Update: 340B Controversies and Outlook video webinar. d/b/a Drug Channels Institute.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Hospitals 40

Drug Channels

JUNE 16, 2021

Despite what you may have heard, the 340B Drug Pricing Program continues to thrive. Drug Channels has exclusively obtained the 2020 amount from the Health Resources and Services Administration (HRSA). d/b/a Drug Channels Institute. Discounted purchases under the program reached at least $38 billion in 2020.

Drug Pricing 40

Drug Pricing Hospitals 40

Drug Channels

DECEMBER 11, 2024

This week, Im rerunning some popular posts while I prepare for Fridays Drug Channels Outlook 2025 live video webinar. If this clip whets your appetite for more, register to watch a replay of the full 90-minute video webinar from June. 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Drug Pricing 52

Drug Pricing Documentation Hospitals 52

Drug Channels

JANUARY 14, 2025

During my recent Drug Channels Outlook 2025 video webinar, I tackled a wide range of crucial topicsincluding the controversial 340B Drug Pricing Program. As I explain in this video excerpt, we may finally see reform of this rapidly expanding program.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

MARCH 18, 2025

Pharmacies and PBMs, Examining $683 Billion Market Review pricing/license options and download the full 2025 report Order before March 31, 2025 to receive special discounted pricing! drug pricing, reimbursement, and dispensing system. prescription drug channels. Want to bundle the report with DCIs video webinars ?

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Hospitals 52

STAT

FEBRUARY 24, 2025

UnitedHealth’s ‘great opportunity’ for its employees The corporate-speak was thick during UnitedHealth Group’s employee webinar last week, when it announced buyout offers for thousands of employees who work in the UnitedHealthcare insurance division. Tell me about good shoes: bob.herman@statnews.com.

Drug Pricing 271

Drug Pricing Drug Development Hospitals 271